Barentz appoints Daniel Hitz as CEO, APAC
Hitz shall assume new role from January 17th, 2022
Hitz shall assume new role from January 17th, 2022
Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever
If approved or authorized, Paxlovid would be the first oral antiviral of its kind, to combat SARS-CoV-2
Filing marks first protein-based vaccine submitted to MHRA for authorization
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
If approved it will bring a second source of MMR vaccine to the US market
Subscribe To Our Newsletter & Stay Updated